XML 39 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Revenue Recognition and Collaborative Arrangements (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Revenue Recognition and Collaborative Arrangements    
Total net revenue from GSK $ 55,183 $ 52,380
GSK    
Revenue Recognition and Collaborative Arrangements    
Total net revenue from GSK 55,183 52,380
GSK | Royalty revenue from a related party    
Revenue Recognition and Collaborative Arrangements    
Royalties from a related party 58,639 55,836
Less: amortization of capitalized fees paid to a related party (3,456) (3,456)
GSK | RELVAR/BREO    
Revenue Recognition and Collaborative Arrangements    
Royalties from a related party 42,740 46,160
GSK | ANORO    
Revenue Recognition and Collaborative Arrangements    
Royalties from a related party 8,570 8,724
GSK | TRELEGY    
Revenue Recognition and Collaborative Arrangements    
Royalties from a related party $ 7,329 $ 952